Back
Mobile-health Network Solutions Vs. CytoMed Therapeutics Industry Stock Comparison
Sell
40
MNDR
Mobile-health Network Solutions
Last Price:
0.44
Seasonality Move:
--
Buy
75
GDTC
CytoMed Therapeutics
Last Price:
2.49
Seasonality Move:
3.7%
Sell
40
Mobile-health Network Solutions (MNDR)
is a Sell
Is Mobile-health Network Solutions a Buy, Sell or Hold?
- The current Mobile-health Network Solutions [MNDR] share price is $0.44. The Score for MNDR is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
- MNDR is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
75
CytoMed Therapeutics (GDTC)
is a Buy
Is CytoMed Therapeutics a Buy, Sell or Hold?
- The current CytoMed Therapeutics [GDTC] share price is $2.62. The Score for GDTC is 75, which is 50% above its historic median score of 50, and infers lower risk than normal.
- GDTC is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
MNDR Stock Price Chart
What is Mobile-health Network Solutions's stock price today?
-
The Mobile-health Network Solutions share price today is $0.44
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and MNDR is experiencing slight buying pressure.
GDTC Stock Price Chart
What is CytoMed Therapeutics's stock price today?
-
The CytoMed Therapeutics share price today is $2.62
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and GDTC is experiencing slight buying pressure.
MNDR Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.06 | Sell |
| Relative Strength Index (14 RSI): | 37.06 | Sell |
| Chaikin Money Flow: | 2830 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (0.44 - 0.56) | Sell |
| Bollinger Bands (100): | (0.56 - 1.26) | Sell |
GDTC Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.18 | Buy |
| Relative Strength Index (14 RSI): | 60.98 | Buy |
| Chaikin Money Flow: | 820 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.91 - 2.59) | Buy |
| Bollinger Bands (100): | (1.55 - 2.23) | Buy |
MNDR Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 0.46 | Sell |
| 20-day SMA: | 0.48 | Sell |
| 50-day SMA: | 0.63 | Sell |
| 200-day SMA: | 0 | Buy |
| 8-day EMA: | 0.45 | Sell |
| 20-day EMA: | 0.5 | Sell |
| 50-day EMA: | 0.77 | Sell |
| 200-day EMA: | 0.09 | Buy |
GDTC Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 2.47 | Buy |
| 20-day SMA: | 2.35 | Buy |
| 50-day SMA: | 1.88 | Buy |
| 200-day SMA: | 2.11 | Buy |
| 8-day EMA: | 2.47 | Buy |
| 20-day EMA: | 2.33 | Buy |
| 50-day EMA: | 2.07 | Buy |
| 200-day EMA: | 2.22 | Buy |
Mobile-health Network Solutions Earnings Growth & MNDR Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and an increase next year of $0.08 per share.
CytoMed Therapeutics Earnings Growth & GDTC Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.11 per share, and a decrease next year of $0.02 per share.
Mobile-health Network Solutions Technical Analysis
| Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 23 | 24 | 25 | 28 | 29 | 30 | 31 | 01 | 04 | 05 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
CytoMed Therapeutics Technical Analysis
| Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 23 | 24 | 25 | 28 | 29 | 30 | 31 | 01 | 04 | 05 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||